GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Applied DNA Sciences Inc (NAS:APDN) » Definitions » Beneish M-Score

Applied DNA Sciences (Applied DNA Sciences) Beneish M-Score : 23.27 (As of Apr. 27, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Applied DNA Sciences Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 23.27 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Applied DNA Sciences's Beneish M-Score or its related term are showing as below:

APDN' s Beneish M-Score Range Over the Past 10 Years
Min: -9.36   Med: -2.63   Max: 23.27
Current: 23.27

During the past 13 years, the highest Beneish M-Score of Applied DNA Sciences was 23.27. The lowest was -9.36. And the median was -2.63.


Applied DNA Sciences Beneish M-Score Historical Data

The historical data trend for Applied DNA Sciences's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Applied DNA Sciences Beneish M-Score Chart

Applied DNA Sciences Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.81 -3.87 2.99 -2.68 17.11

Applied DNA Sciences Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.78 -1.54 -1.53 17.11 23.27

Competitive Comparison of Applied DNA Sciences's Beneish M-Score

For the Diagnostics & Research subindustry, Applied DNA Sciences's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Applied DNA Sciences's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Applied DNA Sciences's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Applied DNA Sciences's Beneish M-Score falls into.



Applied DNA Sciences Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Applied DNA Sciences for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.2383+0.528 * 0.8719+0.404 * 75.8132+0.892 * 0.467+0.115 * 0.9286
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 2.1783+4.679 * -0.577524-0.327 * 1.9645
=23.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $0.45 Mil.
Revenue was 0.891 + 0.78 + 2.917 + 4.408 = $9.00 Mil.
Gross Profit was 0.231 + 0.079 + 1.269 + 1.807 = $3.39 Mil.
Total Current Assets was $4.59 Mil.
Total Assets was $9.91 Mil.
Property, Plant and Equipment(Net PPE) was $1.66 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.32 Mil.
Selling, General, & Admin. Expense(SGA) was $13.21 Mil.
Total Current Liabilities was $2.59 Mil.
Long-Term Debt & Capital Lease Obligation was $0.61 Mil.
Net Income was -1.105 + -3.592 + -3.1 + 0.588 = $-7.21 Mil.
Non Operating Income was 2.625 + 0.514 + -0.282 + 3.252 = $6.11 Mil.
Cash Flow from Operations was -3.758 + -2.68 + -1.369 + 0.214 = $-7.59 Mil.
Total Receivables was $4.05 Mil.
Revenue was 5.263 + 3.559 + 4.296 + 6.147 = $19.27 Mil.
Gross Profit was 2.378 + 0.417 + 1.039 + 2.488 = $6.32 Mil.
Total Current Assets was $18.33 Mil.
Total Assets was $20.30 Mil.
Property, Plant and Equipment(Net PPE) was $1.87 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.31 Mil.
Selling, General, & Admin. Expense(SGA) was $12.99 Mil.
Total Current Liabilities was $3.33 Mil.
Long-Term Debt & Capital Lease Obligation was $0.00 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(0.451 / 8.996) / (4.053 / 19.265)
=0.050133 / 0.210382
=0.2383

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(6.322 / 19.265) / (3.386 / 8.996)
=0.32816 / 0.37639
=0.8719

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (4.59 + 1.657) / 9.913) / (1 - (18.332 + 1.866) / 20.297)
=0.369817 / 0.004878
=75.8132

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=8.996 / 19.265
=0.467

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.309 / (1.309 + 1.866)) / (1.323 / (1.323 + 1.657))
=0.412283 / 0.44396
=0.9286

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(13.21 / 8.996) / (12.987 / 19.265)
=1.46843 / 0.674124
=2.1783

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((0.607 + 2.588) / 9.913) / ((0 + 3.33) / 20.297)
=0.322304 / 0.164064
=1.9645

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-7.209 - 6.109 - -7.593) / 9.913
=-0.577524

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Applied DNA Sciences has a M-score of 23.27 signals that the company is likely to be a manipulator.


Applied DNA Sciences Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Applied DNA Sciences's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Applied DNA Sciences (Applied DNA Sciences) Business Description

Traded in Other Exchanges
Address
50 Health Sciences Drive, Stony Brook, New York, NY, USA, 11790
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) nd ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.
Executives
Clay Shorrock officer: Chief Legal Officer C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Scott L Anchin director 16990 GOLDENTOP ROAD, SUITE A, SAN DIEGO CA 92127
William W Montgomery 10 percent owner 34211 SEAVEY LOOP RD., EUGENE OR 97405
Judith Murrah officer: Chief Information Officer C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Beth Jantzen officer: Chief Financial Officer C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Yacov A Shamash director
Robert B Catell director 62 OSBORNE ROAD, GARDEN CITY NY 11530
John Iii Bitzer director C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Joseph D. Ceccoli director C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Elizabeth M. Ferguson director 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Charles S. Ryan director C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
James A Hayward director, officer: Chief Executive Officer C/O 25 HEALTH SCIENCES DRIVE, SUITE 113, NEW YORK NY 11790
Karol Gray officer: Chief Financial Officer C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Ming-hwa Benjamin Liang officer: Strategic Tech. Dev. Officer C/O APPLIED DNA SCIENCES, INC., 50 HEALTH SCIENCES DRIVE, STONY BROOK NY 11790
Yacov Shamash director 100 ENGINEERING, STATE UNIVERSITY OF NY, STONE BROOK NY 117942200

Applied DNA Sciences (Applied DNA Sciences) Headlines

From GuruFocus